Myocardial fibrosis evaluated by look-locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: Association with ventricular tachyarrhythmia and risk factors

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 2, 2014, Pages 407-412

  Amano, Yasuo ^a   Takeda, Minako ^a   Tachi, Masaki ^a   Kitamura, Mitsunobu ^a   Kumita, Shinichiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

apical hypertrophic cardiomyopathy; arrhythmia; magnetic resonance imaging; myocardial fibrosis; risk factor

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FAINTNESS; FAMILY HISTORY; FEMALE; HEALTH CARE; HEART EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL SCAR; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; TACHYCARDIA; ALGORITHM; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC USE; FIBROSIS; IMAGE ENHANCEMENT; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR;

ADULT; AGED; ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR;

EID: 84904542331     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24357     Document Type: Article

References (31)

1. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y,. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Jpn Heart J 1976; 17: 611-629.
2. Maron BJ, Bonow RO, Seshagiri TNR, Roberts WC, Epstein SE,. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982; 49: 1838-1847.
3. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 638-645. (Pubitemid 34158160)
4. Okishige K, Sasano T, Yano K, Azegami K, Suzuki K, Itoh K,. Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern Med 2001; 40: 396-402. (Pubitemid 33664508)
5. Furushima H, Chinushi M, Iijima K, et al. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy. J Cardiovasc Electrophysiol 2010; 21: 991-999.
6. Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008; 118: 1541-1549.
7. Yamada M, Teraoka K, Kawade M, Hirano M, Yamashina A,. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging 2009; 25 (Suppl 1): 131-138.
8. Tsukamoto M, Hirasaki S, Kuribayashi T, et al. Systolic outward motion of the left ventricular apical wall as detected by magnetic resonance tagging in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2006; 8: 453-460.
9. Amano Y, Takayama M, Fukushima Y, Kitamura M, Kumita S,. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI. Acta Radiol 2011; 52: 613-618.
10. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ,. Toward clinical risk assessment in hypertrophic cardiomyopathy with cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-1567. (Pubitemid 36543376)
11. Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 2006; 27: 1725-1731. (Pubitemid 44025360)
12. Amano Y, Takayama M, Kumita S,. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy. J Magn Reson Imaging 2009; 30: 778-784.
13. Sueyoshi E, Sakamoto I, Uetani M,. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study. AJR Am J Roentgenol 2010; 194: W293-W298.
14. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JAC,. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.
15. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ,. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 2012; 14: 76.
16. Look DC, Locker DR,. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970; 41: 250-251.
17. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223. (Pubitemid 32151298)
18. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264. (Pubitemid 38757595)
19. Harrigan CJ, Peters DC, Gibson CM, et al. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR. Radiology 2011; 258: 128-133.
20. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 2002; 105: 539-542. (Pubitemid 34262671)
21. Maron BJ,. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010; 121: 445-456.
22. Deichmann R, Hahn D, Haase A,. Fast T1 mapping on a whole-body scanner. Magn Reson Med 1999; 42: 206-209.
23. Kim KH, Kim HK, Hwang IC, et al. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with 'pure' apical hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012; 14: 52.
24. Todiere G, Aquaro GD, Piaggi P, et al. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2012; 60: 922-929.
25. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M,. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 42: 288-295. (Pubitemid 36851420)
26. Kellman P, Wilson JR, Xue H, et al. Extracellular volume fraction mapping in the myocardium. Part 2: Initial clinical experience. J Cardiovasc Magn Reson 2012; 14: 64.
27. Nakanishi S, Nishiyama S, Nishimura S, Yamaguchi H, Matsuya S,. Histological features of apical hypertrophic cardiomyopathy. J Cardiogr 1985; 15 (Suppl VI): 3-11. (Pubitemid 15225408)
28. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1369-1374. (Pubitemid 351443083)
29. Kwon DH, Setser RM, Popovic ZB, et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 2008; 24: 617-625.
30. Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-time mortality. Circulation 2012; 126: 1206-1216.
31. Kawel N, Nacif M, Santini F, et al. Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine. J Magn Reson Imaging 2012; 36: 733-737.